highly significantP =8 × 10 −6
6a ), the difference between the predicted drug sensitivity in multiple myeloma patients was highly significant ( P =8 × 10 −6 from a t -test) between trial-defined responder groups and non-responder groups.
6a ), the difference between the predicted drug sensitivity in multiple myeloma patients was highly significant ( P =8 × 10 −6 from a t -test) between trial-defined responder groups and non-responder groups.